Due to the COVID-19 pandemic, the global Penicillin market size is estimated to be worth US$ 1879.1 million in 2021 and is forecast to a readjusted size of US$ 2442.6 million by 2028 with a CAGR of 3.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Penicillin market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Penicillin landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Aminopenicillins accounting for % of the Penicillin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Penicillin include GSK, Pfizer, Johnson & Johnson, Bayer HealthCare, Abbot Laboratories, Roche Pharmaceuticals, Sanofi Aventis, Takeda Pharmaceutical Company and Toyama Chemical and etc. In terms of revenue, the global 3 largest players have a % market share of Penicillin in 2021.
This report focuses on Penicillin volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Penicillin market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Request for a free sample or purchase this report at: https://www.themarketreports.com/report/global-penicillin-market-research-report
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
- Antipseudomonal Penicillins
- Beta-lactamase Inhibitors
- Natural Penicillins
- Penicillinase Resistant Penicillins
Segment by Application
- Johnson & Johnson
- Bayer Healthcare
- Abbot Laboratories
- Roche Pharmaceuticals
- Sanofi Aventis
- Takeda Pharmaceutical Company
- Toyama Chemical
- Merck & Co.
Production by Region
- North America
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Mr. Shirish Gupta
The Market Reports | Industry and Market Reports at its Best
Call: +1-631-407-1315 / +91-750-729-1479